Signaling Pathways - Sphingosine kinases (SphKs) - IMPDH - Bcl-2 - CSF-1R
清除全部
- B5978 BDA-366Target: Bcl-2Summary: BCL2 BH4 结构域的选择性拮抗剂
- B5953 Dovitinib (TKI258) LactateTarget: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: 酪氨酸激酶抑制剂(TKI)
- B4902 (+)-Apogossypol中文名: 變棉子酚,阿朴棉子酚,变棉子酚Target: Bcl-2Summary: Bcl-2家族蛋白抑制剂
- B4899 BLZ9451 CitationTarget: CSF-1RSummary: CSF-1R激酶抑制剂
- B1298 K145Target: Sphingosine kinases (SphKs)Summary: SphK2抑制剂
- B1112 MerimepodibTarget: IMPDHSummary: IMPDH(肌苷单磷酸脱氢酶)的新型非竞争性抑制剂
- B2226 SKI IITarget: Sphingosine kinases (SphKs)Summary: 鞘氨醇激酶(SK)抑制剂
- A1655 GW25801 CitationTarget: CSF-1RSummary: CFMS激酶/CSF-1R抑制剂
- A3717 PF-5431 CitationTarget: Sphingosine kinases (SphKs)Summary: SphK1选择性抑制剂
- A4199 Sabutoclax2 CitationTarget: Bcl-2|Mcl-1|Bfl-1Summary: Pan-Bcl-2抑制剂